202 related articles for article (PubMed ID: 28704484)
1. Apoptosis by [Pt(O,O'-acac)(γ-acac)(DMS)] requires PKC-δ mediated p53 activation in malignant pleural mesothelioma.
Muscella A; Vetrugno C; Cossa LG; Antonaci G; Barca A; De Pascali SA; Fanizzi FP; Marsigliante S
PLoS One; 2017; 12(7):e0181114. PubMed ID: 28704484
[TBL] [Abstract][Full Text] [Related]
2. In Vitro and In Vivo Antitumor Activity of [Pt(O,O'-acac)(γ-acac)(DMS)] in Malignant Pleural Mesothelioma.
Muscella A; Vetrugno C; Cossa LG; Antonaci G; De Nuccio F; De Pascali SA; Fanizzi FP; Marsigliante S
PLoS One; 2016; 11(11):e0165154. PubMed ID: 27806086
[TBL] [Abstract][Full Text] [Related]
3. The signalling axis mediating neuronal apoptosis in response to [Pt(O,O'-acac)(γ-acac)(DMS)].
Muscella A; Calabriso N; Vetrugno C; Fanizzi FP; De Pascali SA; Marsigliante S
Biochem Pharmacol; 2011 Jun; 81(11):1271-85. PubMed ID: 21420390
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of ZL55 cell proliferation by ADP via PKC-dependent signalling pathway.
Muscella A; Cossa LG; Vetrugno C; Antonaci G; Marsigliante S
J Cell Physiol; 2018 Mar; 233(3):2526-2536. PubMed ID: 28777435
[TBL] [Abstract][Full Text] [Related]
5. Response of Cisplatin Resistant Skov-3 Cells to [Pt(
De Castro F; Benedetti M; Antonaci G; Del Coco L; De Pascali SA; Muscella A; Marsigliante S; Fanizzi FP
Molecules; 2018 Sep; 23(9):. PubMed ID: 30205612
[TBL] [Abstract][Full Text] [Related]
6. PKC-δ/PKC-α activity balance regulates the lethal effects of cisplatin.
Muscella A; Vetrugno C; Antonaci G; Cossa LG; Marsigliante S
Biochem Pharmacol; 2015 Nov; 98(1):29-40. PubMed ID: 26300055
[TBL] [Abstract][Full Text] [Related]
7. Sublethal concentrations of the platinum(II) complex [Pt(O,O'-acac)(gamma-acac)(DMS)] alter the motility and induce anoikis in MCF-7 cells.
Muscella A; Calabriso N; Vetrugno C; Urso L; Fanizzi FP; De Pascali SA; Marsigliante S
Br J Pharmacol; 2010 Jul; 160(6):1362-77. PubMed ID: 20590627
[TBL] [Abstract][Full Text] [Related]
8. [Pt(
Antonaci G; Cossa LG; Muscella A; Vetrugno C; De Pascali SA; Fanizzi FP; Marsigliante S
Biomolecules; 2019 Mar; 9(3):. PubMed ID: 30845773
[TBL] [Abstract][Full Text] [Related]
9. [Pt(O,O'-acac)(gamma-acac)(DMS)], a new Pt compound exerting fast cytotoxicity in MCF-7 breast cancer cells via the mitochondrial apoptotic pathway.
Muscella A; Calabriso N; Fanizzi FP; De Pascali SA; Urso L; Ciccarese A; Migoni D; Marsigliante S
Br J Pharmacol; 2008 Jan; 153(1):34-49. PubMed ID: 18026127
[TBL] [Abstract][Full Text] [Related]
10. Synergistic targeting of malignant pleural mesothelioma cells by MDM2 inhibitors and TRAIL agonists.
Urso L; Cavallari I; Silic-Benussi M; Biasini L; Zago G; Calabrese F; Conte PF; Ciminale V; Pasello G
Oncotarget; 2017 Jul; 8(27):44232-44241. PubMed ID: 28562336
[TBL] [Abstract][Full Text] [Related]
11. A new platinum(II) compound anticancer drug candidate with selective cytotoxicity for breast cancer cells.
Muscella A; Vetrugno C; Fanizzi FP; Manca C; De Pascali SA; Marsigliante S
Cell Death Dis; 2013 Sep; 4(9):e796. PubMed ID: 24030148
[TBL] [Abstract][Full Text] [Related]
12. Different apoptotic effects of [Pt(O,O'-acac)(γ-acac)(DMS)] and cisplatin on normal and cancerous human epithelial breast cells in primary culture.
Vetrugno C; Muscella A; Fanizzi FP; Cossa LG; Migoni D; De Pascali SA; Marsigliante S
Br J Pharmacol; 2014 Nov; 171(22):5139-53. PubMed ID: 24990093
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of [Pt(O,O'-acac)(γ-acac)(DMS)] in mouse xenograft model of breast cancer.
Muscella A; Vetrugno C; Migoni D; Biagioni F; Fanizzi FP; Fornai F; De Pascali SA; Marsigliante S
Cell Death Dis; 2014 Jan; 5(1):e1014. PubMed ID: 24457958
[TBL] [Abstract][Full Text] [Related]
14. [Pt(O,O'-acac)(γ-acac)(DMS)] alters SH-SY5Y cell migration and invasion by the inhibition of Na+/H+ exchanger isoform 1 occurring through a PKC-ε/ERK/mTOR Pathway.
Muscella A; Vetrugno C; Calabriso N; Cossa LG; De Pascali SA; Fanizzi FP; Marsigliante S
PLoS One; 2014; 9(11):e112186. PubMed ID: 25372487
[TBL] [Abstract][Full Text] [Related]
15. ADP sensitizes ZL55 cells to the activity of cisplatin.
Muscella A; Cossa LG; Vetrugno C; Antonaci G; Marsigliante S
J Cell Physiol; 2019 Apr; 234(4):4409-4417. PubMed ID: 30144378
[TBL] [Abstract][Full Text] [Related]
16. The platinum (II) complex [Pt(O,O'-acac)(γ-acac)(DMS)] alters the intracellular calcium homeostasis in MCF-7 breast cancer cells.
Muscella A; Calabriso N; Vetrugno C; Fanizzi FP; De Pascali SA; Storelli C; Marsigliante S
Biochem Pharmacol; 2011 Jan; 81(1):91-103. PubMed ID: 20854797
[TBL] [Abstract][Full Text] [Related]
17. Zoledronic acid produces antitumor effects on mesothelioma through apoptosis and S-phase arrest in p53-independent and Ras prenylation-independent manners.
Okamoto S; Kawamura K; Li Q; Yamanaka M; Yang S; Fukamachi T; Tada Y; Tatsumi K; Shimada H; Hiroshima K; Kobayashi H; Tagawa M
J Thorac Oncol; 2012 May; 7(5):873-82. PubMed ID: 22481236
[TBL] [Abstract][Full Text] [Related]
18. New platinum(II) complexes containing both an O,O'-chelated acetylacetonate ligand and a sulfur ligand in the platinum coordination sphere induce apoptosis in HeLa cervical carcinoma cells.
Muscella A; Calabriso N; De Pascali SA; Urso L; Ciccarese A; Fanizzi FP; Migoni D; Marsigliante S
Biochem Pharmacol; 2007 Jun; 74(1):28-40. PubMed ID: 17481588
[TBL] [Abstract][Full Text] [Related]
19. Antitumour and antiangiogenic activities of [Pt(O,O'-acac)(γ-acac)(DMS)] in a xenograft model of human renal cell carcinoma.
Muscella A; Vetrugno C; Biagioni F; Calabriso N; Calierno MT; Fornai F; De Pascali SA; Marsigliante S; Fanizzi FP
Br J Pharmacol; 2016 Sep; 173(17):2633-44. PubMed ID: 27351124
[TBL] [Abstract][Full Text] [Related]
20. [Pt(O,O'-acac)(γ-acac)(DMS)] versus cisplatin: apoptotic effects in B50 neuroblastoma cells.
Grimaldi M; Santin G; Insolia V; Dal Bo V; Piccolini VM; Veneroni P; Barni S; Verri M; De Pascali SA; Fanizzi FP; Bernocchi G; Bottone MG
Histochem Cell Biol; 2016 May; 145(5):587-601. PubMed ID: 26748644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
